Acquisition by Brent Warner of 111700 shares of Poseida Therapeutics at 4.13 subject to Rule 16b-3

PSTXDelisted Stock  USD 9.50  0.08  0.84%   
Slightly above 62% of Poseida Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Poseida Therapeutics stock suggests that many investors are alarmed at this time. Poseida Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Poseida Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Poseida Therapeutics Officer: President, Gene Therapy. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 111700 employee stock option (right to buy) at 4.13 of Poseida Therapeutics by Brent Warner on 1st of March 2024. This event was filed by Poseida Therapeutics with SEC on 2024-03-01. Statement of changes in beneficial ownership - SEC Form 4

Poseida Therapeutics Fundamental Analysis

We analyze Poseida Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poseida Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poseida Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Poseida Therapeutics is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Poseida Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Poseida Therapeutics stock to make a market-neutral strategy. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics with similar companies.

Peers

Poseida Therapeutics Related Equities

LTRNLantern Pharma   5.71   
0%
26.0%
RVMDRevolution Medicines   5.25   
0%
24.0%
DYNDyne Therapeutics   4.43   
0%
20.0%
STOKStoke Therapeutics   4.00   
0%
18.0%
RVPHReviva Pharmaceuticals   2.79   
0%
12.0%
CYTKCytokinetics   2.71   
0%
12.0%
CUECue Biopharma   1.49   
0%
6.0%
PHVSPharvaris   0.51   
0%
2.0%
PLRXPliant Therapeutics   0.19   
1.0%
0%
MLYSMineralys Therapeutics,   0.58   
2.0%
0%
ANTXAN2 Therapeutics   0.85   
3.0%
0%
MOLNMolecular Partners   0.96   
4.0%
0%
IPSCCentury Therapeutics   3.53   
16.0%
0%
PASGPassage Bio   4.92   
22.0%
0%
GBIOGeneration Bio   5.81   
26.0%
0%
INABIn8bio   7.41   
34.0%
0%
PEPGPepGen   21.74   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Poseida Stock

If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges